nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—umbilical vein—urinary bladder cancer	0.0658	0.227	CbGeAlD
Rescinnamine—ACE—urine—urinary bladder cancer	0.0531	0.183	CbGeAlD
Rescinnamine—SLC18A2—prostate gland—urinary bladder cancer	0.0279	0.0964	CbGeAlD
Rescinnamine—ACE—prostate gland—urinary bladder cancer	0.0191	0.0658	CbGeAlD
Rescinnamine—ACE—seminal vesicle—urinary bladder cancer	0.0161	0.0557	CbGeAlD
Rescinnamine—SLC18A2—female reproductive system—urinary bladder cancer	0.0152	0.0526	CbGeAlD
Rescinnamine—ACE—epithelium—urinary bladder cancer	0.014	0.0483	CbGeAlD
Rescinnamine—SLC18A2—vagina—urinary bladder cancer	0.0138	0.0476	CbGeAlD
Rescinnamine—ACE—smooth muscle tissue—urinary bladder cancer	0.0135	0.0466	CbGeAlD
Rescinnamine—ACE—renal system—urinary bladder cancer	0.013	0.0448	CbGeAlD
Rescinnamine—ACE—urethra—urinary bladder cancer	0.0128	0.0441	CbGeAlD
Rescinnamine—ACE—female reproductive system—urinary bladder cancer	0.0104	0.0359	CbGeAlD
Rescinnamine—SLC18A2—lymph node—urinary bladder cancer	0.00892	0.0308	CbGeAlD
Rescinnamine—ACE—lymph node—urinary bladder cancer	0.00609	0.021	CbGeAlD
Rescinnamine—Dermatitis—Valrubicin—urinary bladder cancer	0.00366	0.00515	CcSEcCtD
Rescinnamine—Headache—Valrubicin—urinary bladder cancer	0.00364	0.00512	CcSEcCtD
Rescinnamine—Psoriasis—Epirubicin—urinary bladder cancer	0.00361	0.00509	CcSEcCtD
Rescinnamine—Dermatitis bullous—Gemcitabine—urinary bladder cancer	0.0036	0.00507	CcSEcCtD
Rescinnamine—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.00354	0.00499	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Doxorubicin—urinary bladder cancer	0.00353	0.00497	CcSEcCtD
Rescinnamine—Nausea—Valrubicin—urinary bladder cancer	0.00345	0.00486	CcSEcCtD
Rescinnamine—Pain—Mitomycin—urinary bladder cancer	0.00342	0.00482	CcSEcCtD
Rescinnamine—Redness—Epirubicin—urinary bladder cancer	0.00336	0.00474	CcSEcCtD
Rescinnamine—Psoriasis—Doxorubicin—urinary bladder cancer	0.00334	0.00471	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Epirubicin—urinary bladder cancer	0.00333	0.00469	CcSEcCtD
Rescinnamine—Herpes zoster—Methotrexate—urinary bladder cancer	0.00322	0.00454	CcSEcCtD
Rescinnamine—Redness—Doxorubicin—urinary bladder cancer	0.00311	0.00438	CcSEcCtD
Rescinnamine—Gingivitis—Methotrexate—urinary bladder cancer	0.00309	0.00435	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Doxorubicin—urinary bladder cancer	0.00308	0.00434	CcSEcCtD
Rescinnamine—Abscess—Methotrexate—urinary bladder cancer	0.00307	0.00432	CcSEcCtD
Rescinnamine—Conjunctivitis—Thiotepa—urinary bladder cancer	0.00307	0.00432	CcSEcCtD
Rescinnamine—Herpes zoster—Epirubicin—urinary bladder cancer	0.00302	0.00425	CcSEcCtD
Rescinnamine—Influenza—Gemcitabine—urinary bladder cancer	0.00298	0.00419	CcSEcCtD
Rescinnamine—Gingivitis—Epirubicin—urinary bladder cancer	0.00289	0.00407	CcSEcCtD
Rescinnamine—Abscess—Epirubicin—urinary bladder cancer	0.00287	0.00404	CcSEcCtD
Rescinnamine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.00285	0.00401	CcSEcCtD
Rescinnamine—Stinging—Epirubicin—urinary bladder cancer	0.0028	0.00395	CcSEcCtD
Rescinnamine—Herpes zoster—Doxorubicin—urinary bladder cancer	0.00279	0.00393	CcSEcCtD
Rescinnamine—Skin discolouration—Methotrexate—urinary bladder cancer	0.00269	0.00378	CcSEcCtD
Rescinnamine—Gingivitis—Doxorubicin—urinary bladder cancer	0.00268	0.00377	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00267	0.00376	CcSEcCtD
Rescinnamine—Abscess—Doxorubicin—urinary bladder cancer	0.00266	0.00374	CcSEcCtD
Rescinnamine—Dizziness—Mitomycin—urinary bladder cancer	0.00265	0.00373	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.00262	0.00368	CcSEcCtD
Rescinnamine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.0026	0.00366	CcSEcCtD
Rescinnamine—Stinging—Doxorubicin—urinary bladder cancer	0.00259	0.00365	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.00257	0.00362	CcSEcCtD
Rescinnamine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.00256	0.0036	CcSEcCtD
Rescinnamine—Urinary tract infection—Fluorouracil—urinary bladder cancer	0.00254	0.00357	CcSEcCtD
Rescinnamine—Conjunctivitis—Fluorouracil—urinary bladder cancer	0.00254	0.00357	CcSEcCtD
Rescinnamine—Rash—Mitomycin—urinary bladder cancer	0.00252	0.00355	CcSEcCtD
Rescinnamine—Dermatitis—Mitomycin—urinary bladder cancer	0.00252	0.00355	CcSEcCtD
Rescinnamine—Skin discolouration—Epirubicin—urinary bladder cancer	0.00251	0.00354	CcSEcCtD
Rescinnamine—Headache—Mitomycin—urinary bladder cancer	0.00251	0.00353	CcSEcCtD
Rescinnamine—Cough increased—Epirubicin—urinary bladder cancer	0.00248	0.00349	CcSEcCtD
Rescinnamine—Erythema—Thiotepa—urinary bladder cancer	0.00247	0.00347	CcSEcCtD
Rescinnamine—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00246	0.00347	CcSEcCtD
Rescinnamine—Sinusitis—Fluorouracil—urinary bladder cancer	0.00245	0.00345	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.00244	0.00343	CcSEcCtD
Rescinnamine—Vaginal inflammation—Methotrexate—urinary bladder cancer	0.00243	0.00342	CcSEcCtD
Rescinnamine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.00243	0.00341	CcSEcCtD
Rescinnamine—Conjunctivitis—Cisplatin—urinary bladder cancer	0.0024	0.00339	CcSEcCtD
Rescinnamine—Rhinitis—Gemcitabine—urinary bladder cancer	0.00239	0.00336	CcSEcCtD
Rescinnamine—Back pain—Thiotepa—urinary bladder cancer	0.00239	0.00336	CcSEcCtD
Rescinnamine—Nausea—Mitomycin—urinary bladder cancer	0.00238	0.00335	CcSEcCtD
Rescinnamine—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00236	0.00333	CcSEcCtD
Rescinnamine—Rhinitis—Fluorouracil—urinary bladder cancer	0.00235	0.00331	CcSEcCtD
Rescinnamine—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00233	0.00328	CcSEcCtD
Rescinnamine—Skin discolouration—Doxorubicin—urinary bladder cancer	0.00233	0.00328	CcSEcCtD
Rescinnamine—Pharyngitis—Fluorouracil—urinary bladder cancer	0.00233	0.00327	CcSEcCtD
Rescinnamine—Cough increased—Doxorubicin—urinary bladder cancer	0.0023	0.00323	CcSEcCtD
Rescinnamine—Vaginal infection—Methotrexate—urinary bladder cancer	0.00229	0.00323	CcSEcCtD
Rescinnamine—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.00228	0.00321	CcSEcCtD
Rescinnamine—Vaginal inflammation—Epirubicin—urinary bladder cancer	0.00227	0.0032	CcSEcCtD
Rescinnamine—Dermatitis contact—Epirubicin—urinary bladder cancer	0.00224	0.00316	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.00223	0.00315	CcSEcCtD
Rescinnamine—Myocardial infarction—Etoposide—urinary bladder cancer	0.00222	0.00313	CcSEcCtD
Rescinnamine—Cough—Thiotepa—urinary bladder cancer	0.00215	0.00303	CcSEcCtD
Rescinnamine—Vaginal infection—Epirubicin—urinary bladder cancer	0.00214	0.00302	CcSEcCtD
Rescinnamine—Hypertension—Thiotepa—urinary bladder cancer	0.00213	0.003	CcSEcCtD
Rescinnamine—Vaginal inflammation—Doxorubicin—urinary bladder cancer	0.0021	0.00296	CcSEcCtD
Rescinnamine—Myalgia—Thiotepa—urinary bladder cancer	0.0021	0.00296	CcSEcCtD
Rescinnamine—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.00208	0.00292	CcSEcCtD
Rescinnamine—Erythema—Gemcitabine—urinary bladder cancer	0.00207	0.00292	CcSEcCtD
Rescinnamine—Erythema—Fluorouracil—urinary bladder cancer	0.00204	0.00287	CcSEcCtD
Rescinnamine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00202	0.00285	CcSEcCtD
Rescinnamine—Back pain—Gemcitabine—urinary bladder cancer	0.00201	0.00282	CcSEcCtD
Rescinnamine—Infection—Thiotepa—urinary bladder cancer	0.002	0.00281	CcSEcCtD
Rescinnamine—Hypertonia—Epirubicin—urinary bladder cancer	0.00199	0.0028	CcSEcCtD
Rescinnamine—Vaginal infection—Doxorubicin—urinary bladder cancer	0.00198	0.00279	CcSEcCtD
Rescinnamine—Erythema—Cisplatin—urinary bladder cancer	0.00193	0.00272	CcSEcCtD
Rescinnamine—Hypertonia—Doxorubicin—urinary bladder cancer	0.00184	0.00259	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00183	0.00258	CcSEcCtD
Rescinnamine—Cough—Gemcitabine—urinary bladder cancer	0.00181	0.00255	CcSEcCtD
Rescinnamine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00181	0.00254	CcSEcCtD
Rescinnamine—Hypertension—Gemcitabine—urinary bladder cancer	0.00179	0.00252	CcSEcCtD
Rescinnamine—Myalgia—Gemcitabine—urinary bladder cancer	0.00177	0.00249	CcSEcCtD
Rescinnamine—Discomfort—Gemcitabine—urinary bladder cancer	0.00174	0.00246	CcSEcCtD
Rescinnamine—Myalgia—Fluorouracil—urinary bladder cancer	0.00174	0.00244	CcSEcCtD
Rescinnamine—Dysgeusia—Etoposide—urinary bladder cancer	0.00173	0.00244	CcSEcCtD
Rescinnamine—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00172	0.00243	CcSEcCtD
Rescinnamine—Constipation—Thiotepa—urinary bladder cancer	0.00172	0.00242	CcSEcCtD
Rescinnamine—Pain—Thiotepa—urinary bladder cancer	0.00172	0.00242	CcSEcCtD
Rescinnamine—Discomfort—Fluorouracil—urinary bladder cancer	0.00172	0.00242	CcSEcCtD
Rescinnamine—Back pain—Etoposide—urinary bladder cancer	0.00171	0.00241	CcSEcCtD
Rescinnamine—Oedema—Gemcitabine—urinary bladder cancer	0.00169	0.00238	CcSEcCtD
Rescinnamine—Infection—Gemcitabine—urinary bladder cancer	0.00168	0.00237	CcSEcCtD
Rescinnamine—Oedema—Fluorouracil—urinary bladder cancer	0.00166	0.00234	CcSEcCtD
Rescinnamine—Infection—Fluorouracil—urinary bladder cancer	0.00165	0.00233	CcSEcCtD
Rescinnamine—Myalgia—Cisplatin—urinary bladder cancer	0.00165	0.00232	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00165	0.00232	CcSEcCtD
Rescinnamine—Discomfort—Cisplatin—urinary bladder cancer	0.00163	0.00229	CcSEcCtD
Rescinnamine—Urticaria—Thiotepa—urinary bladder cancer	0.0016	0.00225	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.0016	0.00225	CcSEcCtD
Rescinnamine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00159	0.00224	CcSEcCtD
Rescinnamine—Oedema—Cisplatin—urinary bladder cancer	0.00158	0.00222	CcSEcCtD
Rescinnamine—Infection—Cisplatin—urinary bladder cancer	0.00157	0.00221	CcSEcCtD
Rescinnamine—Cough—Etoposide—urinary bladder cancer	0.00155	0.00218	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00154	0.00217	CcSEcCtD
Rescinnamine—Insomnia—Gemcitabine—urinary bladder cancer	0.00153	0.00216	CcSEcCtD
Rescinnamine—Hypertension—Etoposide—urinary bladder cancer	0.00153	0.00215	CcSEcCtD
Rescinnamine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00152	0.00214	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00152	0.00213	CcSEcCtD
Rescinnamine—Insomnia—Fluorouracil—urinary bladder cancer	0.00151	0.00212	CcSEcCtD
Rescinnamine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00149	0.0021	CcSEcCtD
Rescinnamine—Discomfort—Etoposide—urinary bladder cancer	0.00149	0.0021	CcSEcCtD
Rescinnamine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00148	0.00209	CcSEcCtD
Rescinnamine—Gastritis—Epirubicin—urinary bladder cancer	0.00146	0.00205	CcSEcCtD
Rescinnamine—Constipation—Gemcitabine—urinary bladder cancer	0.00145	0.00204	CcSEcCtD
Rescinnamine—Pain—Gemcitabine—urinary bladder cancer	0.00145	0.00204	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00144	0.00202	CcSEcCtD
Rescinnamine—Infection—Etoposide—urinary bladder cancer	0.00144	0.00202	CcSEcCtD
Rescinnamine—Influenza—Epirubicin—urinary bladder cancer	0.00142	0.00201	CcSEcCtD
Rescinnamine—Pruritus—Thiotepa—urinary bladder cancer	0.00142	0.002	CcSEcCtD
Rescinnamine—Pain—Fluorouracil—urinary bladder cancer	0.00142	0.002	CcSEcCtD
Rescinnamine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00142	0.00199	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00139	0.00196	CcSEcCtD
Rescinnamine—Angina pectoris—Epirubicin—urinary bladder cancer	0.00139	0.00195	CcSEcCtD
Rescinnamine—Bronchitis—Epirubicin—urinary bladder cancer	0.00137	0.00193	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—urinary bladder cancer	0.00135	0.0019	CcSEcCtD
Rescinnamine—Pain—Cisplatin—urinary bladder cancer	0.00135	0.0019	CcSEcCtD
Rescinnamine—Dizziness—Thiotepa—urinary bladder cancer	0.00133	0.00187	CcSEcCtD
Rescinnamine—Urticaria—Fluorouracil—urinary bladder cancer	0.00132	0.00186	CcSEcCtD
Rescinnamine—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00132	0.00186	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—urinary bladder cancer	0.00132	0.00186	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.0013	0.00183	CcSEcCtD
Rescinnamine—Paraesthesia—Etoposide—urinary bladder cancer	0.0013	0.00183	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00128	0.00181	CcSEcCtD
Rescinnamine—Rash—Thiotepa—urinary bladder cancer	0.00127	0.00179	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—urinary bladder cancer	0.00127	0.00179	CcSEcCtD
Rescinnamine—Dermatitis—Thiotepa—urinary bladder cancer	0.00127	0.00178	CcSEcCtD
Rescinnamine—Headache—Thiotepa—urinary bladder cancer	0.00126	0.00177	CcSEcCtD
Rescinnamine—Pain—Etoposide—urinary bladder cancer	0.00124	0.00174	CcSEcCtD
Rescinnamine—Constipation—Etoposide—urinary bladder cancer	0.00124	0.00174	CcSEcCtD
Rescinnamine—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00123	0.00174	CcSEcCtD
Rescinnamine—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00123	0.00174	CcSEcCtD
Rescinnamine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00123	0.00173	CcSEcCtD
Rescinnamine—Pharyngitis—Methotrexate—urinary bladder cancer	0.00121	0.0017	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.0012	0.00169	CcSEcCtD
Rescinnamine—Pruritus—Gemcitabine—urinary bladder cancer	0.0012	0.00169	CcSEcCtD
Rescinnamine—Nausea—Thiotepa—urinary bladder cancer	0.0012	0.00168	CcSEcCtD
Rescinnamine—Sinusitis—Epirubicin—urinary bladder cancer	0.00119	0.00168	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00118	0.00166	CcSEcCtD
Rescinnamine—Pruritus—Fluorouracil—urinary bladder cancer	0.00118	0.00166	CcSEcCtD
Rescinnamine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00116	0.00164	CcSEcCtD
Rescinnamine—Urticaria—Etoposide—urinary bladder cancer	0.00115	0.00162	CcSEcCtD
Rescinnamine—Rhinitis—Epirubicin—urinary bladder cancer	0.00114	0.00161	CcSEcCtD
Rescinnamine—Abdominal pain—Etoposide—urinary bladder cancer	0.00114	0.00161	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00114	0.00161	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00114	0.00161	CcSEcCtD
Rescinnamine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00113	0.0016	CcSEcCtD
Rescinnamine—Pharyngitis—Epirubicin—urinary bladder cancer	0.00113	0.00159	CcSEcCtD
Rescinnamine—Sinusitis—Doxorubicin—urinary bladder cancer	0.0011	0.00155	CcSEcCtD
Rescinnamine—Dizziness—Fluorouracil—urinary bladder cancer	0.0011	0.00155	CcSEcCtD
Rescinnamine—Rash—Gemcitabine—urinary bladder cancer	0.00107	0.0015	CcSEcCtD
Rescinnamine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00107	0.0015	CcSEcCtD
Rescinnamine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00106	0.0015	CcSEcCtD
Rescinnamine—Erythema—Methotrexate—urinary bladder cancer	0.00106	0.00149	CcSEcCtD
Rescinnamine—Headache—Gemcitabine—urinary bladder cancer	0.00106	0.00149	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—urinary bladder cancer	0.00106	0.00149	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00105	0.00148	CcSEcCtD
Rescinnamine—Rash—Fluorouracil—urinary bladder cancer	0.00105	0.00148	CcSEcCtD
Rescinnamine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00105	0.00148	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00105	0.00147	CcSEcCtD
Rescinnamine—Headache—Fluorouracil—urinary bladder cancer	0.00104	0.00147	CcSEcCtD
Rescinnamine—Dysgeusia—Methotrexate—urinary bladder cancer	0.00104	0.00146	CcSEcCtD
Rescinnamine—Back pain—Methotrexate—urinary bladder cancer	0.00103	0.00144	CcSEcCtD
Rescinnamine—Pruritus—Etoposide—urinary bladder cancer	0.00102	0.00144	CcSEcCtD
Rescinnamine—Nausea—Gemcitabine—urinary bladder cancer	0.00101	0.00142	CcSEcCtD
Rescinnamine—Rash—Cisplatin—urinary bladder cancer	0.000995	0.0014	CcSEcCtD
Rescinnamine—Dermatitis—Cisplatin—urinary bladder cancer	0.000994	0.0014	CcSEcCtD
Rescinnamine—Erythema—Epirubicin—urinary bladder cancer	0.000993	0.0014	CcSEcCtD
Rescinnamine—Nausea—Fluorouracil—urinary bladder cancer	0.000989	0.00139	CcSEcCtD
Rescinnamine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000972	0.00137	CcSEcCtD
Rescinnamine—Back pain—Epirubicin—urinary bladder cancer	0.00096	0.00135	CcSEcCtD
Rescinnamine—Dizziness—Etoposide—urinary bladder cancer	0.000956	0.00135	CcSEcCtD
Rescinnamine—Nausea—Cisplatin—urinary bladder cancer	0.000937	0.00132	CcSEcCtD
Rescinnamine—Cough—Methotrexate—urinary bladder cancer	0.000926	0.0013	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—urinary bladder cancer	0.000919	0.00129	CcSEcCtD
Rescinnamine—Rash—Etoposide—urinary bladder cancer	0.000911	0.00128	CcSEcCtD
Rescinnamine—Dermatitis—Etoposide—urinary bladder cancer	0.000911	0.00128	CcSEcCtD
Rescinnamine—Headache—Etoposide—urinary bladder cancer	0.000906	0.00127	CcSEcCtD
Rescinnamine—Myalgia—Methotrexate—urinary bladder cancer	0.000903	0.00127	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.0009	0.00127	CcSEcCtD
Rescinnamine—Discomfort—Methotrexate—urinary bladder cancer	0.000892	0.00126	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—urinary bladder cancer	0.000889	0.00125	CcSEcCtD
Rescinnamine—Cough—Epirubicin—urinary bladder cancer	0.000866	0.00122	CcSEcCtD
Rescinnamine—Infection—Methotrexate—urinary bladder cancer	0.00086	0.00121	CcSEcCtD
Rescinnamine—Nausea—Etoposide—urinary bladder cancer	0.000859	0.00121	CcSEcCtD
Rescinnamine—Hypertension—Epirubicin—urinary bladder cancer	0.000857	0.00121	CcSEcCtD
Rescinnamine—Myalgia—Epirubicin—urinary bladder cancer	0.000845	0.00119	CcSEcCtD
Rescinnamine—Discomfort—Epirubicin—urinary bladder cancer	0.000835	0.00118	CcSEcCtD
Rescinnamine—Oedema—Epirubicin—urinary bladder cancer	0.00081	0.00114	CcSEcCtD
Rescinnamine—Infection—Epirubicin—urinary bladder cancer	0.000805	0.00113	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—urinary bladder cancer	0.000802	0.00113	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—urinary bladder cancer	0.000793	0.00112	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000789	0.00111	CcSEcCtD
Rescinnamine—Insomnia—Methotrexate—urinary bladder cancer	0.000783	0.0011	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—urinary bladder cancer	0.000782	0.0011	CcSEcCtD
Rescinnamine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000777	0.00109	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—urinary bladder cancer	0.000773	0.00109	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—urinary bladder cancer	0.00075	0.00106	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—urinary bladder cancer	0.000745	0.00105	CcSEcCtD
Rescinnamine—Pain—Methotrexate—urinary bladder cancer	0.00074	0.00104	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000738	0.00104	CcSEcCtD
Rescinnamine—Insomnia—Epirubicin—urinary bladder cancer	0.000733	0.00103	CcSEcCtD
Rescinnamine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000728	0.00102	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000708	0.000997	CcSEcCtD
Rescinnamine—Pain—Epirubicin—urinary bladder cancer	0.000693	0.000976	CcSEcCtD
Rescinnamine—Constipation—Epirubicin—urinary bladder cancer	0.000693	0.000976	CcSEcCtD
Rescinnamine—Urticaria—Methotrexate—urinary bladder cancer	0.000688	0.000968	CcSEcCtD
Rescinnamine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000684	0.000964	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000683	0.000962	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—urinary bladder cancer	0.000678	0.000955	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000673	0.000948	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000663	0.000933	CcSEcCtD
Rescinnamine—Urticaria—Epirubicin—urinary bladder cancer	0.000644	0.000906	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—urinary bladder cancer	0.000641	0.000903	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—urinary bladder cancer	0.000641	0.000903	CcSEcCtD
Rescinnamine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000641	0.000902	CcSEcCtD
Rescinnamine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000638	0.000898	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000613	0.000863	CcSEcCtD
Rescinnamine—Pruritus—Methotrexate—urinary bladder cancer	0.000613	0.000862	CcSEcCtD
Rescinnamine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000597	0.00084	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—urinary bladder cancer	0.000596	0.000839	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000593	0.000834	CcSEcCtD
Rescinnamine—Pruritus—Epirubicin—urinary bladder cancer	0.000573	0.000807	CcSEcCtD
Rescinnamine—Dizziness—Methotrexate—urinary bladder cancer	0.000573	0.000806	CcSEcCtD
Rescinnamine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000552	0.000778	CcSEcCtD
Rescinnamine—Rash—Methotrexate—urinary bladder cancer	0.000546	0.000769	CcSEcCtD
Rescinnamine—Dermatitis—Methotrexate—urinary bladder cancer	0.000545	0.000768	CcSEcCtD
Rescinnamine—Headache—Methotrexate—urinary bladder cancer	0.000542	0.000764	CcSEcCtD
Rescinnamine—Dizziness—Epirubicin—urinary bladder cancer	0.000536	0.000754	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—urinary bladder cancer	0.00053	0.000747	CcSEcCtD
Rescinnamine—Nausea—Methotrexate—urinary bladder cancer	0.000514	0.000724	CcSEcCtD
Rescinnamine—Rash—Epirubicin—urinary bladder cancer	0.000511	0.000719	CcSEcCtD
Rescinnamine—Dermatitis—Epirubicin—urinary bladder cancer	0.00051	0.000719	CcSEcCtD
Rescinnamine—Headache—Epirubicin—urinary bladder cancer	0.000508	0.000715	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—urinary bladder cancer	0.000496	0.000698	CcSEcCtD
Rescinnamine—Nausea—Epirubicin—urinary bladder cancer	0.000481	0.000678	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—urinary bladder cancer	0.000473	0.000666	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000472	0.000665	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—urinary bladder cancer	0.00047	0.000661	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—urinary bladder cancer	0.000445	0.000627	CcSEcCtD
